Cost-Effectiveness Analysis of Memantine for Moderate-To-Severe Alzheimer's Disease in the Netherlands
Neuropsychiatric Disease and Treatment - New Zealand
doi 10.2147/ndt.s19239
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2011
Authors
Publisher
Informa UK Limited